Hubble Therapeutics

Hanover, NH · Founded 2000 · Privately Held (backing)

Developer of a gene therapy platform designed for a rare genetic eye disorder that typically presents with severe progressive visual impairment. Hubble Therapeutics is based in Hanover, NH and was founded in 2000. It has raised $20.3 million across 1 recorded round; the latest was a $9.8 million early-stage round in Oct 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$20.3M
Last round
Early Stage VC
Oct 2024
How much has Hubble Therapeutics raised?
$20.3Macross 1 recorded rounds · Oct 2024 – Oct 2024

Most recently, Hubble Therapeutics raised $9.8M in its Early Stage VC (Oct 2024).

Private Market View
More of Hubble Therapeutics with a free Private Market View account
  • ·Watch Hubble Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Hubble Therapeutics round by round

1 rounds
Oct 2024Early Stage VC$9.8MSEC filing▮
17 investors participated

How much has Hubble Therapeutics raised?

Hubble Therapeutics has raised $20.3 million in total; 1 of its rounds is on record. The largest on record was a $9.8 million early-stage round in Oct 2024.

Hubble Therapeutics has filed 1 Form D with the SEC, most recently in Oct 2024 ($9.8 million sold to 17 investors).

Hubble Therapeutics investors

4 investors are on record for Hubble Therapeutics, including WARF Ventures, Wisconsin Alumni Research Foundation, Bluestem Capital Company and Visionary Venture Fund. The early-stage round in Oct 2024 drew 17 investors.

For fundraisers
Raising for a company like Hubble Therapeutics?

4 investors have backed Hubble Therapeutics.

See all 4 investors →

Frequently asked about Hubble Therapeutics

How much has Hubble Therapeutics raised?
Hubble Therapeutics has raised $20.3M in total across 1 recorded funding rounds.
When was Hubble Therapeutics's last funding round?
Hubble Therapeutics's most recent recorded round was Early Stage VC in Oct 2024, raising $9.8M.